MX9606374A - Derivados de benzoilecgonina, ecgonina y ecgonidina acoplados de modo covalente. - Google Patents

Derivados de benzoilecgonina, ecgonina y ecgonidina acoplados de modo covalente.

Info

Publication number
MX9606374A
MX9606374A MX9606374A MX9606374A MX9606374A MX 9606374 A MX9606374 A MX 9606374A MX 9606374 A MX9606374 A MX 9606374A MX 9606374 A MX9606374 A MX 9606374A MX 9606374 A MX9606374 A MX 9606374A
Authority
MX
Mexico
Prior art keywords
disorders
ecgonine
benzoylecgonine
ecgonidine derivatives
relates
Prior art date
Application number
MX9606374A
Other languages
English (en)
Inventor
James E Wynn
Lowell M Somers
Original Assignee
Entropin Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entropin Inc filed Critical Entropin Inc
Publication of MX9606374A publication Critical patent/MX9606374A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La presente invencion se refiere a una nueva clase de derivados de benzoilecgonina, ecgonina y ecgonidina acoplados de modo covalente que son utiles para aliviar los síntomas de enfermedades del sistema inmunorregulador, enfermedades neuromusculares, enfermedades de las articulaciones, enfermedades del tejido conectador, enfermedades circulatorias y dolor. De acuerdo con lo anterior, la presente invencion se refiere a composiciones farmacéuticas y los métodos para su uso.
MX9606374A 1994-06-16 1995-06-07 Derivados de benzoilecgonina, ecgonina y ecgonidina acoplados de modo covalente. MX9606374A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/260,054 US5525613A (en) 1994-06-16 1994-06-16 Covalently coupled benzoylecgonine ecgonine and ecgonidine
PCT/US1995/007268 WO1995034561A1 (en) 1994-06-16 1995-06-07 Benzoylecgonine, ecgonine and ecgonidine derivatives

Publications (1)

Publication Number Publication Date
MX9606374A true MX9606374A (es) 1997-03-29

Family

ID=22987610

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9606374A MX9606374A (es) 1994-06-16 1995-06-07 Derivados de benzoilecgonina, ecgonina y ecgonidina acoplados de modo covalente.

Country Status (21)

Country Link
US (1) US5525613A (es)
EP (2) EP1466913A1 (es)
JP (1) JP2951409B2 (es)
KR (1) KR100407458B1 (es)
CN (1) CN1046511C (es)
AT (1) ATE255108T1 (es)
AU (1) AU693571B2 (es)
CA (1) CA2190611A1 (es)
DE (1) DE69532203T2 (es)
DK (1) DK0765326T3 (es)
ES (1) ES2210296T3 (es)
HK (1) HK1012626A1 (es)
HU (1) HU224634B1 (es)
IL (1) IL114177A (es)
MX (1) MX9606374A (es)
NO (1) NO965276D0 (es)
NZ (1) NZ288844A (es)
PL (1) PL186000B1 (es)
PT (1) PT765326E (es)
WO (1) WO1995034561A1 (es)
ZA (1) ZA955002B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270766B1 (en) * 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
US5763456A (en) * 1995-06-07 1998-06-09 Entropin, Inc. Benzoylecgonine, ecgonine and ecgonidine derivatives
US6482831B1 (en) 1994-06-16 2002-11-19 Entropin, Inc. Covalently coupled benzoylecgonine, egconine and ecgonidine derivatives
US6103698A (en) * 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
WO2003042209A1 (en) 2001-11-13 2003-05-22 Entropin, Inc. Novel benzoylecgonine compositions and methods for producing them
TW200418856A (en) * 2002-12-05 2004-10-01 Entropin Inc Novel tropane esters and methods for producing and using them
TW200808739A (en) * 2006-04-06 2008-02-16 Novartis Vaccines & Diagnostic Quinazolines for PDK1 inhibition
DK2018380T3 (da) 2006-05-19 2012-01-23 Abbott Lab CNS-aktiverede kondenserede bi-heterocyklisk-substituerede azabicykliske alkanderivater

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2893996A (en) * 1957-10-14 1959-07-07 Grace W R & Co N-amino derivatives of tropine alkaloids
US2948730A (en) * 1959-02-04 1960-08-09 Grace W R & Co 8-aminotropanium compounds
US4469700A (en) * 1981-06-19 1984-09-04 Lowell M. Somers Benzoylecgonine or benzoylnorecgonine as active agents for the treatment of rheumatoid arthritis
US4556663A (en) * 1982-12-13 1985-12-03 Somers Lowell M Benzoylecgonine, benzoylnorecgonine and ecgonine as active agents for the treatment of rheumatoid arthritis and osteoarthritis
US4512996A (en) * 1982-12-13 1985-04-23 Lowell Somers Benzoylecgonine or benzoylnorecgonine as active agents for the treatment of rheumatoid arthritis
FR2569563B1 (fr) * 1984-09-03 1987-07-03 Somers Lowell Formulation a base de benzoylecgonine ou de benzoylnorecgonine pour le traitement du rhumatisme articulaire
US5376667A (en) * 1992-12-31 1994-12-27 Entropin, Inc. Derivatives of benzoylecgonine, ecgonine and their multiple pharmacological properties

Also Published As

Publication number Publication date
PL317754A1 (en) 1997-04-28
KR100407458B1 (ko) 2004-03-26
CN1046511C (zh) 1999-11-17
NO965276L (no) 1996-12-10
DE69532203T2 (de) 2004-09-09
US5525613A (en) 1996-06-11
JP2951409B2 (ja) 1999-09-20
IL114177A (en) 2000-02-17
ATE255108T1 (de) 2003-12-15
JPH09510991A (ja) 1997-11-04
HU224634B1 (hu) 2005-12-28
HUT75869A (en) 1997-05-28
AU2820095A (en) 1996-01-05
HU9603443D0 (en) 1997-02-28
IL114177A0 (en) 1995-10-31
EP0765326B1 (en) 2003-11-26
ZA955002B (en) 1996-02-08
HK1012626A1 (en) 1999-08-06
AU693571B2 (en) 1998-07-02
NO965276D0 (no) 1996-12-10
ES2210296T3 (es) 2004-07-01
DK0765326T3 (da) 2004-04-05
EP0765326A1 (en) 1997-04-02
NZ288844A (en) 1998-05-27
CN1150802A (zh) 1997-05-28
DE69532203D1 (de) 2004-01-08
EP1466913A1 (en) 2004-10-13
WO1995034561A1 (en) 1995-12-21
CA2190611A1 (en) 1995-12-21
PL186000B1 (pl) 2003-09-30
PT765326E (pt) 2004-03-31

Similar Documents

Publication Publication Date Title
MY130145A (en) Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders.
EP0703785B8 (en) Methods for treating muscle diseases and disorders
WO1999064059A3 (en) Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
HU9602522D0 (en) Heterocyclic compounds, their preparation and use
MX9606374A (es) Derivados de benzoilecgonina, ecgonina y ecgonidina acoplados de modo covalente.
GR3006815T3 (es)
IL108193A0 (en) Benzoylecgonine, ecgonine and ecgonidine derivatives, pharmaceutical compositions containing the same, and methods for the preparation therof
TW198685B (es)
AU3963797A (en) Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety
MX9702253A (es) Nuevos estrenos para inducir efectos hipotalamicos
MD1140B1 (en) Remedy possessing a regenerative and cytoprotective activity
AU2596195A (en) Substituted alkyldiamine derivatives and their use as tachykinin antagonists
ZA947401B (en) Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles
WO2004052888A3 (en) Tropane esters and methods for producing and using them
AU3978095A (en) Heterocyclic compounds and their preparation and use